Organogenesis Holdings Stock Investor Sentiment
| ORGO Stock | USD 2.86 0.07 2.51% |
About 55% of Organogenesis Holdings' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Organogenesis Holdings suggests that some traders are interested. Organogenesis Holdings' investor sentiment overview provides quick insight into current market opportunities from investing in Organogenesis Holdings. The current market sentiment, together with Organogenesis Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Organogenesis Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Organogenesis Holdings stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Organogenesis daily returns and investor perception about the current price of Organogenesis Holdings as well as its diversification or hedging effects on your existing portfolios.
Organogenesis |
Organogenesis Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Organogenesis Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Organogenesis Holdings that are available to investors today. That information is available publicly through Organogenesis media outlets and privately through word of mouth or via Organogenesis internal channels. However, regardless of the origin, that massive amount of Organogenesis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organogenesis Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organogenesis Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organogenesis Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organogenesis Holdings alpha.
Organogenesis Holdings Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Disposition of 791 shares by Patrick Bilbo of Organogenesis Holdings at 3.48 subject to Rule 16b-3 | 02/16/2024 |
2 | Payment of 8657 shares by Montecalvo Antonio S of Organogenesis Holdings subject to Rule 16b-3 | 02/20/2024 |
3 | Acquisition by Duraibabu Prathyusha of 51020 shares of Organogenesis Holdings subject to Rule 16b-3 | 02/21/2024 |
4 | Acquisition by David Francisco of 160350 shares of Organogenesis Holdings subject to Rule 16b-3 | 02/23/2024 |
5 | Organogenesis Holdings Inc Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 | 02/29/2024 |
6 | Why Organogenesis Holding Stock Plummeted by 18 percent Today | 03/01/2024 |
7 | AQR Capital Management LLC Decreases Stake in Organogenesis Holdings Inc. - Defense World | 03/13/2024 |
8 | Disposition of 152250 shares by Patrick Bilbo of Organogenesis Holdings at 1.18 subject to Rule 16b-3 | 03/28/2024 |
9 | Disposition of 10113 shares by Gillheeney Gary S. of Organogenesis Holdings at 2.8 subject to Rule 16b-3 | 04/01/2024 |
10 | Is Organogenesis Holdings Using Too Much Debt | 04/10/2024 |
11 | SG Americas Securities LLC Acquires 6727 Shares of Organogenesis Holdings Inc. - Defense World | 04/17/2024 |
Check out Organogenesis Holdings Hype Analysis, Organogenesis Holdings Correlation and Organogenesis Holdings Performance. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.301 | Quarterly Revenue Growth (0.14) | Return On Assets 0.0224 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.